30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

venBio Global Strategic Fund, L.P.

Insider profile

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
venBio Global Strategic Fund, L.P.'s trades of Metacrine, Inc.'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-10-26 2021-10-25 S Sale
38,854 -10.7%
127.85
US$1,927,557
38,854 -10.7% 127.85 US$1,927,557
2021-10-26 2021-10-22 S Sale
56,145 -32.8%
60.90
US$901,597
56,145 -32.8% 60.90 US$901,597
2020-09-22 2020-09-18 B Purchase
62,521 +27.1%
309.34
US$1,610,933
62,521 +27.1% 309.34 US$1,610,933
2019-04-01 2019-04-01 B Purchase
50,000 +inf%
16.00
US$800,000
50,000 +inf% 16.00 US$800,000